Tuesday, November 10, 2026
Biotech

FDA Flags Vision Risk for Popular Weight-Loss Drugs

Health officials warn that drugs like Wegovy and Zepbound might link to a rare eye problem.

Millions of Americans take new drugs for weight loss. Now, health regulators urge doctors and patients to watch out for eye trouble.

The Food and Drug Administration issued a new safety alert. The agency found signs of a rare condition that causes vision loss. This problem links to popular shots like Wegovy and Zepbound.

Doctors use these medicines to manage diabetes and body weight. The eye risk remains small, but the damage can be permanent. Patients should contact their doctors right away if their sight gets blurry.

These treatments still help many people reach a healthy weight. Staying alert helps you protect your sight while you hit your goals.

Source: CNBC

#Biotech#FDA#Wegovy#Zepbound#Health

More from Biotech